Jay Lichter's Net Worth
$300 Thousand
Who is Jay Lichter?
Jay Lichter does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Janux Therapeutics, Inc., Synthorx, Inc., ARATANA THERAPEUTICS, INC., OTONOMY, INC., and AKESIS PHARMACEUTICALS, INC..
SEC CIK
Jay Lichter's CIK is 0001376355
Past Insider Trading and Trends
2015 was Jay Lichter's most active year for acquiring shares with 2 total transactions. Jay Lichter's most active month to acquire stocks was the month of May. 2020 was Jay Lichter's most active year for disposing of shares, totalling 2 transactions. Jay Lichter's most active month to dispose stocks was the month of December. 2007 saw Jay Lichter paying a total of $0.00 for 500,000 shares, this is the most they've acquired in one year. In 2020 Jay Lichter cashed out on 45,335 shares for a total of $2,562,626.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$31.99 | -$112,133.30 | 7K |
Sep 13
| |||
Form 4
| -11.38% | -1.66M |
$33.24 | -$77,250,360.93 | 12.94M |
Oct 16 - Oct 18
| |||
Form 4
| -4.41% | -451.09K |
$46.71 | -$21,153,619.49 | 9.77M |
Sep 10 - Sep 12
| |||
Form 4
| -3.31% | -240.08K |
$30.06 | -$10,134,526.16 | 7.01M |
Sep 6 - Sep 9
| |||
Form 4
| +54.55% | 2.5K |
—
|
—
| 7.08K |
Jun 26
| |||
Form 4
| -17.15% | -1.50M |
$54.75 | -$82,125,000.00 | 7.24M |
Jun 3
| |||
Form 4
|
∞
| 849.85K |
$5.87 | $4,988,642.98 | 849.85K |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +4,514.47% | 8.67M |
$17.00 |
—
| 8.87M |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synthorx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.28M |
$68.00 | -$155,084,404.00 |
0
|
Jan 23
| |||
Form 4
| -87.40% | -4.15M |
—
|
—
| 598.57K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +3,334.62% | 6.24M |
$11.00 |
—
| 6.43M |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARATANA THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.89% | -1.00M |
—
|
—
| 2.35M |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| -19.78% | -825.00K |
$19.00 | -$15,675,000.00 | 3.35M |
Feb 3
| |||
Form 4/A
| +13.62% | 500K |
$6.00 | $3,000,000.00 | 4.17M |
Jul 2
| |||
Form 4
| +1,455.78% | 3.43M |
—
|
—
| 3.67M |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OTONOMY, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| -100.00% | -321.18K |
$2.70 | -$866,543.64 |
0
|
Mar 3
| |||
Form 4
| -73.57% | -893.83K |
$2.87 | -$2,560,930.05 | 321.18K |
Feb 26 - Mar 2
| |||
Form 4
| -47.11% | -1.08M |
$2.95 | -$3,193,662.76 | 1.22M |
Feb 23 - Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +1.42% | 32.21K |
$16.27 | $637.93 | 2.3M |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +106.28% | 2.26M |
$14.20 | $1,749,970.69 | 4.38M |
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AKESIS PHARMACEUTICALS, INC. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15 - Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||